View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: December 22, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Smithfield Foods Distributes 1,000 Holiday Hams to Fight Hunger in Ham...

Smithfield Foods Distributes 1,000 Holiday Hams to Fight Hunger in Hampton Roads SMITHFIELD, Va., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Smithfield Foods, in collaboration with , distributed 1,000 free holiday hams and grocery bags filled with side dishes as part of its Season of Serving food distribution event, providing a complete meal to neighbors facing hunger in Southeastern Virginia. “The Tidewater region of Virginia has been our home for nearly 90 years, and we are deeply committed to supporting our neighbors,” said Shane Smith, president and CEO of Smithfield Foods. “Through our partn...

 PRESS RELEASE

Celanese Announces Early Results and Upsize of Tender Offers for 6.665...

Celanese Announces Early Results and Upsize of Tender Offers for 6.665% Senior Notes due 2027 and 6.850% Senior Notes due 2028 DALLAS, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Celanese Corporation (NYSE: CE) (“Celanese”), a global chemical and specialty materials company, today announced the early results of offers by its direct wholly-owned subsidiary Celanese US Holdings LLC (the “Company”) to purchase for cash validly tendered (and not validly withdrawn) and accepted notes in an aggregate principal amount equal to (i) $946,106,000 of 6.665% Senior Notes due 2027 (the “2027 Notes”) and (ii) $2...

 PRESS RELEASE

CECO Environmental Secures Record Order Exceeding $135 Million

CECO Environmental Secures Record Order Exceeding $135 Million Full Year 2025 Bookings Expected to Surpass $1 Billion ADDISON, Texas, Dec. 15, 2025 (GLOBE NEWSWIRE) -- CECO Environmental Corp. (Nasdaq: CECO) ("CECO" or the "Company"), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment, and industrial equipment, announced today it has booked its largest ever order exceeding $135 million. The order includes a comprehensive emissions management solution designed to deliver ultra-low emissions and acoustic and thermal performanc...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: December 13, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Asa Gold & Precious Metals Ltd: 1 director

Two Directors at Asa Gold & Precious Metals Ltd bought/sold 10,897 shares at between 53.806USD and 54.090USD. The significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company...

Celanese Corp: 1 director

A director at Celanese Corp bought 5,000 shares at 41.030USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

Geoffrey Von Der Ahe ... (+3)
  • Geoffrey Von Der Ahe
  • Ritika Das
  • Robert Driscoll
 PRESS RELEASE

Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI™ (Z...

Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI™ (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML – 86% (32/37) CRc and 73% (27/37) CR in newly diagnosed NPM1-m AML, with 68% (17/25) of CRc responders achieving molecular MRD negativity by central NGS  – Median duration of complete response and overall survival not yet reached in newly diagnosed NPM1-m patients as of data cutoff – – 65% (31/48) ORR in R/R NPM1-m AML, 83% (19/23) ORR in venetoclax-naïve – – 41% (13/32) ORR in R/R KMT2A-r AML, 70% (7/10) ORR in venetoclax-naïve –...

 PRESS RELEASE

Kura Oncology to Host Virtual Investor Event to Discuss Data Presented...

Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI®) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid Leukemia Event Scheduled for December 8, 2025 at 12:30 PM ET SAN DIEGO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will be hosting a virtual analyst and investor event on Monday, December 8, 2025, at 12:30 ...

 PRESS RELEASE

Celanese Announces Cash Tender Offers for up to $1,000,000,000 Aggrega...

Celanese Announces Cash Tender Offers for up to $1,000,000,000 Aggregate Principal Amount of 6.665% Senior Notes due 2027 and 6.850% Senior Notes due 2028 DALLAS, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Celanese Corporation (NYSE: CE) (“Celanese”), a global chemical and specialty materials company, today announced that its direct wholly-owned subsidiary Celanese US Holdings LLC (the “Company”) has commenced offers to purchase for cash up to $1,000,000,000 aggregate principal amount (as such amount may be increased or decreased subject to applicable law, the “Maximum Tender Amount”) of its outst...

 PRESS RELEASE

First U.S. Commercial Sale of KOMZIFTI™ Triggers $135 Million Mileston...

First U.S. Commercial Sale of KOMZIFTI™ Triggers $135 Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin SAN DIEGO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA, “Kura”), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced the first U.S. commercial sale of KOMZIFTI™ (ziftomenib) has been completed. Under Kura’s collaboration and license agreement with Kyowa Kirin Co. Ltd. and Kyowa Kirin, Inc. (collectively, “Kyowa Kirin”), this milestone...

David Nierengarten ... (+9)
  • David Nierengarten
  • Dennis Pak
  • Geoffrey Von Der Ahe
  • Laura Chico
  • Martin Fan
  • Ritika Das
  • Robert Driscoll
  • Thomas Yip
  • Yun Zhong
 PRESS RELEASE

KOMZIFTI™ (ziftomenib) Added to National Comprehensive Cancer Network®...

KOMZIFTI™ (ziftomenib) Added to National Comprehensive Cancer Network® (NCCN) Guidelines for Acute Myeloid Leukemia (AML) KOMZIFTI, the first and only once-daily FDA-approved menin inhibitor for R/R NPM1-mutated AML, is now commercially available in the United States SAN DIEGO and TOKYO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA, “Kura”) and Kyowa Kirin Co., Ltd. (TSE: 4151, “Kyowa Kirin”) today announced KOMZIFTI™ (ziftomenib), the first and only once-daily oral menin inhibitor to be approved for adults with relapsed or refractory acute myeloid leukemia (AML) ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch